Premium
Fatal Myocardial Infarction Associated with Bromocriptine for Postpartum Lactation Suppression
Author(s) -
Dutt S.,
Wong F.,
Spurway J.H.
Publication year - 1998
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1998.tb02977.x
Subject(s) - bromocriptine , medicine , myocardial infarction , asymptomatic , coronary artery disease , lactation , cardiology , disease , infarction , pregnancy , prolactin , hormone , biology , genetics
Summary: Bromocriptine (Parlodel®) has attracted widespread controversy for its use for postpartum lactation suppression because of recent reports of cerebral and cardiovascular complications. This case describes a maternal death in which bromocriptine therapy may have triggered myocardial infarction in a patient with asymptomatic coronary artery disease. We suggest its use with caution, especially in patients with identifiable risk factors of coronary artery disease or arteriovascular disease.